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Abstract––Using quantitative immunocytochemical procedures, the total number of estrogen and andro-
gen receptors was estimated in a large number of hypothalamic and limbic nuclei of male rats, in which
brain estrogen formation was inhibited neonatally by treatment with the aromatase inhibitor 1,4,6-
androstatriene-3,17-dione. The highest densities of estrogen receptor immunoreactivity were observed in
the periventricular preoptic area and the medial preoptic area. Neonatally estrogen-deprived males
showed a higher estrogen receptor immunoreactivity than control males in the periventricular preoptic
area and the ventrolateral portion of the ventromedial nucleus of the hypothalamus, i.e. those brain areas
in which sex diVerences have been reported, with female rats showing a greater estrogen binding capacity
than male rats. The highest densities of androgen receptor immunoreactivity were found in the
septohypothalamic nucleus, the medial preoptic area, the posterior division of the bed nucleus of the stria
terminalis and the posterodorsal division of the medial amygdaloid nucleus. No significant diVerences in
distribution or total numbers of androgen receptors were found between neonatally estrogen-deprived
males and control males.
These findings suggest that neonatal estrogens, derived from the neural aromatization of testosterone,
are involved in the sexual diVerentiation of the estrogen receptor system in the periventricular preoptic
area and the ventromedial hypothalamus. The role of neonatal estrogens in the development of the
forebrain androgen receptor system is less clear. ? 1997 IBRO. Published by Elsevier Science Ltd.
Key words: neonatal ATD treatment, androgen receptor, estrogen receptor, estrogens, hypothalamus,
preoptic area.
In mammals, testosterone and estradiol derived from
neural aromatization of testosterone act syner-
gistically in the developing male brain to organize its
structures and functions, i.e. to masculinize and
defeminize the neural substrates that later control
sexual behavior and neuroendocrine function. In
the rat brain, masculinization results in the display of
male-typical sexual behavior (mounts, intromissions
and ejaculations) in adulthood. Defeminization re-
sults in a loss of cyclic release of gonadotropins
necessary for ovulation and a loss of female-typical
sexual behavior (lordosis, presenting, ear wiggling,
hop and dart) in adulthood (e.g., Ref. 37). Thus,
gonadally intact male rats display the complete pat-
tern of male coital behavior when pair tested with an
estrous female and no female-typical sexual behavior
when pair tested with a sexually active male. How-
ever, lordosis behavior can be induced in castrated
male rats by administering estradiol and progester-
one, although the behavior displayed is usually less
intense than that of females, and considerably more
estradiol is required for its stimulation.20,42,54
The development of the female rat brain is gener-
ally believed to proceed in the absence of testosterone
and estradiol. Gonadally intact female rats display
periods of behavioral proceptivity, i.e. seeking out
the male partner, and receptivity, i.e. the display of
lordosis in response to mounts, around the time of
ovulation.12 However, male-typical sexual behavior,
such as intromission-like and ejaculation-like behav-
ior, can be induced in ovariectomized female rats
by administering testosterone or estradiol, although
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higher doses are required for its activation than in
castrated male rats.8,11,27,41
These sex diVerences in responsiveness to testoster-
one and estradiol might be influenced by sex diVer-
ences in the concentration and distribution of
androgen and estrogen receptors in the brain. To
date, there is evidence indicating that estrogen and
androgen receptor concentrations are sexually di-
morphic in several areas of the rat brain. Adult
female rats have a higher estrogen binding capacity in
the periventricular preoptic area (PVP), the medial
preoptic area (mPOA), the arcuate nucleus (Arc)
and ventromedial nucleus of the hypothalamus
(VMH) than adult male rats.17,18 Sex diVerences have
also been found in basal estrogen receptor (ER)
mRNA levels in the ventrolateral portion of the
VMH and in the Arc, with female rats showing
higher concentrations than male rats.35 The sex dif-
ferences in ER biosynthesis are already present early
in development.24,33 Using immunocytochemical
procedures, sex diVerences have been found in both
newborn and adult rats, with females showing a
higher density of ER immunoreactivity (ER-IR) than
males.57 Sex diVerences with respect to the androgen
receptor (AR) have also been reported: nuclear AR
concentrations were found to be higher neonatally in
male rats than in female rats; this was most clearly
seen in the amygdala.38 Adult male rats, castrated
and treated with physiological doses of testosterone,
exhibit significantly higher levels of AR binding
compared to similarly treated females in the bed
nucleus of the stria terminalis (BNST), PVP and
VMH.47 Presumably, perinatal androgens are
involved in the sexual diVerentiation of brain ER and
AR.
We have shown previously that male rats in
which brain estrogen formation was inhibited neo-
natally by administration of the steroidal aromatiz-
ation blocker 1,4,6-androstatriene-3,17-dione (ATD)
can readily show male-typical as well as female-
typical sexual behavior (e.g., Refs 3 and 16). In
addition, partner preference of ATD males is also
incompletely diVerentiated: when given free access
to an estrous female and a sexually active male,
ATD males approached both the estrous female to
whom they showed male-typical sexual behavior
(mounts, intromissions, but rarely ejaculations) and
the sexually active male to whom they showed
feminine sexual behavior (lordosis, presenting,
ear wiggling, hop and dart).3,6 Furthermore,
ATD males showed a response to estrogens
which diVered from that of control males. After
castration and estradiol treatment in adulthood,
ATD males displayed high levels of feminine sexual
behavior and showed a clear-cut preference for a
sexually active male over an estrous female. Simi-
larly treated control males displayed high levels of
masculine sexual behavior and showed a clear pref-
erence for an estrous female over a sexually active
male.4,5
In the present study, we evaluated the possible
contribution of neonatal estradiol in the sexual dif-




All animal experiments were carried out in accordance
with the guidelines of the Animal Facility Department of
the Faculty of Medicine and Health Sciences, Erasmus
University Rotterdam, which in general follow the NIH
guidelines. Male and female Wistar rats (Wu strain,
outbred), obtained commercially (Harlan, Zeist, The
Netherlands), were housed in single-sex groups of two or
three. Food and water were available ad libitum. Female
rats were time-mated and parturition occurred 22 days later.
Within 2–4 h after birth, newborn males received sub-
cutaneously a silastic capsule (SR3: i.d. 1.5 mm, o.d.
2.1 mm, length 5 mm) containing crystalline ATD under ice
anesthesia. Control males received empty silastic capsules.
The implants were removed at 21 days of age and the
animals were housed two to three to a cage of the same
treatment. The males were left undisturbed until the age
of approximately six months. One week before ER
immunocytochemistry, nine ATD and nine control males
were castrated under ether anesthesia through a midline
abdominal incision.
Immunocytochemistry
Males were anesthetized with sodium pentobarbital
(100 mg/rat, i.p.), given an intracardiac injection of heparin
(1000 U/rat) and perfused via the aorta with 0.1 M
phosphate-buVered saline (pH 7.3), followed by 4%
paraformaldehyde in 0.1 M phosphate buVer (300 ml per
animal). Brains were removed and postfixed in 4% para-
formaldehyde for 2 h and placed in 0.1 M phosphate-
buVered saline. Sections of 50 µm were cut on a Vibratome
using ice-cold Tris-buVered saline (TBS; 0.05 M, 0.9%
NaCl, pH 7.6). TBS was used to rinse the sections for at
least 1 h (three times) between all steps of the immunocyto-
chemical procedure. All antibodies were diluted in 0.05 M
TBS containing 0.5 M NaCl and 0.5% Triton X-100 (pH
7.6). For ER-IR, the antibody ER-21 (gift of G. Greene,
University of Chicago), which is a rabbit polyclonal anti-
body directed against the N-terminus (amino acids 1–21),
i.e. the estrogen binding domain of the ER, was used
(1 µg/ml). ER-21 has been validated previously.14,15,39 For
AR-IR, the antibody PG-21 was used (gift of G. Greene,
University of Chicago), which is a rabbit polyclonal anti-
body directed against a synthetic peptide corresponding to
the first 21 amino acids of the rat AR (2 µg/ml; e.g., Ref. 44).
PG-21 has been validated extensively (e.g., Refs 19, 55 and
56).
Free-floating sections were incubated with primary
antiserum (ER-21 or PG-21) and left for 1 h at room
temperature and subsequently at 4)C overnight. Goat anti-
rabbit immunoglobulin (Betsy, 1:100; Netherlands Institute
for Brain Research) was applied for 1 h at room tempera-
ture followed (after rinsing with TBS) by peroxidase–
antiperoxidase (1:1000; Netherlands Institute for Brain
Research) for 1 h. All incubations were done on a rocking
table. As chromogen, 3,3*-diaminobenzidine tetrahydro-
chloride (DAB; 0.5 mg/ml) with 0.01% H2O2 and 0.2%
nickel ammonium sulfate in 0.05 M TBS (pH 7.6) was used.
Sections were then mounted on chrome–alum-coated slides,
dehydrated and coverslipped using entellan.
Quantitative analysis
The densitometrical analyses were performed on an
IBAS-KAT image analysis system (Kontron). The image
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analyser was connected to a Bosch TYK9B TV camera
equipped with a chalnycon tube mounted on a Zeiss micro-
scope. The microscope was equipped with a planapo objec-
tive, a light source connected to a stabilized power supply
and a scanning stage under control of both a joystick and
the image analyser. All measurements were done using a
560-nm small band filter (Schott), which coincides with the
absorption maximum of the DAB–nickel precipitate in
the sections.
For each section, the analysis consisted of the following
steps: (i) loading of an image containing no immunostaining
at a #10 magnification for measurement of the back-
ground; (ii) loading of a #2.5 magnification image covering
that part of the section which contained the area(s) of
interest; (iii) loading of 12 (4#3) 768#512 images with
#10 magnification; (iv) manual outlining of the measuring
areas (anatomical structures) in the reconstituted #2.5
magnification image. With exception of the sexually dimor-
phic nucleus of the preoptic area (SDN-POA), the outlines
of the measuring areas were based on the immunocyto-
chemical staining. For the sexually dimorphic nucleus, some
sections were counterstained with Cresyl Violet in order to
delineate more faithfully the SDN-POA boundaries; (v)
feeding in the computer the names and the left/right side
dimensions of the outlined structures; (vi) calculation of a
mask for the immunoreactive cells in each outlined structure
and measurement of the total area of that mask in each
outlined structure (area mask); (vii) measurement of the
area of the outlined structure (area field); (viii) calculation
of the optical density of the area mask (ODmask), which
measures the concentration of DAB in the outlined area
(mg/µm3); (ix) calculation of the integrated optical density
(IOD; IODmask=ODmask#area mask). In this way, the total
amount of DAB, which is an estimate for the total number
of ER- or AR-IR nuclei, was measured in each outlined
area. The data obtained were first analysed for normal
distribution using the Kolmogorov–Smirnov test and the
group means for each area of interest were subsequently
subjected to Student’s t-test. The P=0.05 level was used as
the upper limit for statistical significance.
RESULTS
Estrogen receptor immunoreactivity
In both ATD and control males, dense popu-
lations of ER-IR cell nuclei were observed in the
PVP, mPOA, BNST, specifically in the anterior and
posterior medial divisions, Arc, ventrolateral por-
tion of the VMH and in the posterodorsal medial
amygdaloid nucleus (MePD). Furthermore, the PVP
and mPOA contained the greatest numbers of ERs.
Examples of ER-IR cell nuclei in the PVP, mPOA
and VMH are shown in Fig. 1. Analysis with
Student’s t-test showed that the total number of
ER-IR nuclei, i.e. the IOD, of ATD males was
significantly higher compared to control males in
the PVP (t=3.39, d.f.=16, P=0.01) and in the VMH
(t=2.42, d.f.=15, P=0.05) (Table 1). ATD males had
similar densities of ERs as control males in the
mPOA, BNST, Arc and MePD (Table 1). Analyses
with Student’s t-test revealed that the total area
occupied by ER-IR cells, i.e. the area mask, was
significantly higher in the PVP (t=4.8, d.f.=16,
P<0.001), the mPOA (t=2.6, d.f.=16, P=0.02) and
the VMH (t=3.6, d.f.=15, P=0.01) of ATD males
compared to control males (Table 1).
Androgen receptor immunoreactivity
In both ATD and control males, AR-IR cell nuclei
were found in the septohypothalamic nucleus, the
mPOA, the SDN-POA, the anterior and posterior
divisions of the BNST, the Arc, the VMH and
through the rostrocaudal extent of the medial
amygdaloid nucleus, i.e. anterior, anteroventral,
anterodorsal, posteroventral and MePD (see Table
2). Furthermore, the greatest numbers of ARs were
observed in the septohypothalamic nucleus, the
mPOA, the posterior division of the BNST, and the
MePD. Examples of AR-IR cell nuclei in the mPOA
containing the SDN-POA, the posterior division of
the BNST, and posterior medial amygdaloid nucleus
are presented in Fig. 2. Analysis with Student’s t-test
revealed that the total amount of AR-IR nuclei, i.e.
the IOD, was similar in ATD and control males for
each area measured (Table 2). Also, no diVerences
between ATD and control males were found in the




Neonatal inhibition of brain estrogen biosynthesis
in male rats increased ER levels in the PVP, an area
known to be involved in gonadotropin release, and
the ventrolateral portion of the VMH. As described
in the Introduction, sex diVerences have been
reported in the PVP and VMH, with female rats
showing a higher estrogen binding capacity18,33 or a
higher ER-IR57 than male rats. Unfortunately, no
female controls were used in the present study. There-
fore, it is not known how closely the ER levels found
in the PVP and VMH of neonatally ATD-treated
males approximate to those found in normal females.
It could be possible that neonatally ATD-treated
males are intermediate between normal males and
females with respect to their ER levels, as was found
earlier with respect to their partner preference.4 This
would suggest that either androgens or prenatal
estrogens are also involved in the sexual diVeren-
tiation of ER levels in the PVP and VMH. Some
supportive evidence for a possible contribution of
prenatal androgens or estrogens to the sexual diVer-
entiation of ER levels includes the finding that neo-
natal castration of male rats did not entirely feminize
their ER levels in the VMH.34 On the other hand,
neonatal castration of male rats increased ER levels
in the PVP, Arc and mPOA to levels indistinguish-
able from those found in normal females,34 suggest-
ing that the sexual diVerentiation of brain ER takes
place primarily neonatally under the influence of
androgens or estrogens.
Neonatal inhibition of brain estrogen biosynthesis
did not aVect ER levels in the Arc and mPOA,
although the total area occupied by ER-IR cells in
the mPOA was higher in neonatally ATD-treated
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males than in control males (see Fig. 1). Ku¨hnemann
et al.33,34 reported that castration immediately after
birth increased ER levels in the Arc and mPOA,
whereas castration one day after birth failed to do so.
Presumably, the sex diVerences in brain estrogen
levels in the mPOA and Arc might represent an
extremely rapid response to the hypothalamic surge
in estradiol occurring in males between 0 h in utero
and 1 h after delivery.46 Since ATD treatment was
not initiated until 2–4 h after birth, ATD males were
most likely exposed to this hypothalamic surge in
estradiol. Therefore, ATD males’ brains could al-
ready have been partly organized in a male direction,
i.e. ER levels were already lowered partly in the
mPOA and almost completely in the Arc. In support
of the role of neonatal estrogen in the sexual diVer-
entiation of ER in the preoptic area are the findings
of DonCarlos et al.25 Female rats neonatally treated
with the synthetic estrogen, diethylstilbestrol, showed
at the age of 28 days reduced ER mRNA levels in the
Fig. 1. Photomicrographs showing ER-IR in neonatally ATD-treated male and control male rats. (A, B)
The PVP of a control male (A) and of an ATD male (B). (C, D) The mPOA of a control male (C) and of
an ATD male (D). (E, F) The VMH of a control male (E) and of an ATD male (F). Scales: 1 cm=195 µm
(A, B); 1 cm=310 µm (C–F).
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preoptic area, comparable to the levels seen in intact
males. The non-aromatizable androgen, dihydrotes-
tosterone, had no eVect on ER mRNA in the pre-
optic area of females.
The sex diVerences in ER levels are presumably
established within 24 h after birth for the PVP and
mPOA, whereas the sex diVerence in the VMH
emerges later, between five and 10 days after birth.33
Thus, sex diVerences in ER levels in diVerent brain
areas seem to be expressed asynchronously, pro-
viding a possible mechanism for variation in the
duration of critical periods for androgen- or
estrogen-mediated sexual diVerentiation of specific
neural functions. For instance, masculinization and
defeminization of sexual behavior are probably two
separable processes, which occur at slightly diVerent
times during development (e.g., Refs 7, 13 and 52).
Our behavioral data suggest that defeminization of
the male rat brain takes place primarily neonatally
under the action of estradiol and that masculiniz-
ation of the brain occurs mainly both prenatally and
immediately after birth under the synergistic action
of testosterone and estradiol.
The sex diVerences in ER levels in the PVP, mPOA,
Arc and VMH may contribute to the regulation
of sex-specific estrogen-dependent functions. For
instance, female rats are capable of showing a pre-
ovulatory luteinizing hormone surge after adult gona-
dectomy and treatment with a large dose of estradiol,
whereas male rats are not.40 Neonatal castration
makes it possible for males to show a preovulatory
luteinizing hormone surge in response to estrogen,
whereas neonatal treatment of female rats with tes-
tosterone eliminates this capacity to exhibit estrogen-
induced surges (for overview see Ref. 26). Whether
functional responses, such as an estrogen-induced
Table 1. Estrogen receptor immunoreactivity of neonatally 1,4,6-androstatriene-3,17-dione-treated male and control male
rats in various hypothalamic and limbic nuclei
Total number of ERs (#103)† Area occupied by ERs (µm3, #103)
Region of labeled cells Control ATD Control ATD
Periventricular preoptic area 10&0.9 15&1.1* 21&0.8 28&1.2*
Medial preoptic area 21&1.9 24&1.4 40&1.8 48&2.2*
Bed nucleus of the stria terminalis
Anterior 5&0.8 5&0.6 16&1.5 19&1.7
Posterior 7&1.2 8&1.2 22&2.2 25&2.5
Arcuate nucleus 7&0.5 7&0.5 13&0.7 13&0.7
Ventromedial hypothalamus 1.9&0.3 2.8&0.2* 5&0.6 8&0.5*
Medial amygdaloid nucleus
Posterodorsal 8&0.9 9&0.9 25&2 26&1.8
†The total number of ER-IR nuclei is estimated by taking the product of the optical density, which measures the
concentration of the chromogen DAB in each outlined area, and the area occupied by ERs.
*Significantly (P<0.05) higher compared to control males.
Data are expressed as mean&S.E.
Table 2. Androgen receptor immunoreactivity of neonatally 1,4,6-androstatriene-3,17-dione-treated male and control male
rats in various limbic and hypothalamic nuclei
Total number of ARs (#103)† Area occupied by ARs (µm3, #103)
Region of labeled cells Control ATD Control ATD
Septohypothalamic nucleus 17&2.4 17&2.9 51&5.3 50&7.0
Medial preoptic area 16&1.2 17&1.6 50&3.0 50&3.0
Sexually dimorphic nucleus 6&0.5 5&0.6 13&1.0 11&0.8
Bed nucleus of the stria terminalis
Anterior 10&0.7 10&1.0 40&2.2 38&3.0
Posterior 22&2.3 25&4.2 71&5.3 77&9.0
Arcuate nucleus 2&0.2 3&0.4 6&0.3 7&0.8
Ventromedial hypothalamus 11&0.7 11&1.4 41&2.3 41&3.9
Medial amygdaloid nucleus
Anterior 4&0.5 5&0.8 20&2.3 25&3.3
Anterodorsal 6&0.6 5&0.7 27&2.2 23&2.5
Anteroventral 4&0.4 3&0.3 13&1.0 12&1.0
Posterodorsal 19&1.8 19&3.3 64&4.7 57&6.0
Posteroventral 4&0.4 4&0.7 15&1.4 16&2.1
†The total number of AR-IR nuclei is estimated by taking the product of the optical density, which measures the
concentration of the chromogen DAB in each outlined area, and the area occupied by ARs.
Data are expressed as mean&S.E.
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luteinizing hormone surge, are directly proportional
to the number of ER-containing neurons in a
particular brain area remains to be investigated.
Interestingly, a co-existence of ER and neurotensin
has been found in the PVP.2 Neurotensin appears
to be involved as an interneuron in the regulation of
the release of luteinizing-releasing hormone (e.g.,
Ref. 1).
For activation of feminine sexual behavior in the
male rat, a much higher dose of estradiol is required
than in the female rat.20,28,42,54 This is confirmed by
previous behavioral findings in our laboratory.4,5
Neonatally ATD-treated male rats, castrated in
adulthood and subsequently treated with estradiol,
show high levels of feminine sexual behavior and a
partner preference for a sexually active male, whereas
similarly treated control males show high levels of
masculine sexual behavior and a partner preference
for an estrous female. Only when treated with ex-
tremely high doses of estradiol (blood serum levels
Fig. 2. Photomicrographs (1 cm=310 µm) showing AR-IR of neonatally ATD-treated male and control
male rats. (A, B) The mPOA including the sexually dimorphic nucleus of a control male (A) and of an
ATD male (B). (C, D) The MePD of a control male (C) and of an ATD male (D). (E, F) The VMH of
a control male (E) and of an ATD male (F).
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1000 pmol/l; normal blood serum levels ~7 pmol/l),
normal males show feminine sexual behaviors
(unpublished observations in our laboratory). These
findings suggest that the reduced capacity to respond
to estrogen in adulthood is associated with lower
levels of ER in the male rat brain.
Meredith et al.39 reported that the ER-21 anti-
serum is able to detect both occupied and unoccupied
ERs in the guinea-pig, since ER-21 immunostaining
was not aVected by a high dose of 17â-estradiol
(50 µg). However, in a pilot study, we found a more
intense staining with the ER-21 antiserum after the
male rats were castrated. It has been reported that
castration leads to an up-regulation of ER mRNA,49
whereas acute estradiol treatment down-regulates ER
mRNA.35 In the present study, castration has pre-
sumably led to an up-regulation of ER in both ATD
and control males, although the possibility cannot be
ruled out that the ER-21 antiserum could be more
eYcient at detecting unoccupied ERs in the rat brain
as opposed to the guinea-pig brain. If ER levels were
up-regulated by castration, then the ER levels in the
present study represent the maximal capacity rather
than physiological levels.
Androgen receptor immunoreactivity
Neonatal inhibition of brain estrogen biosynthesis
in male rats did not aVect forebrain AR levels. This
suggests that neonatal estrogens do not play a signifi-
cant role in the sexual diVerentiation of the forebrain
AR system. However, it is not clear to what extent
ARs are sexually diVerentiated, i.e. sexually dimor-
phic, in adulthood. Reports on sex diVerences in
androgen binding capacity have been conflicting.
Biochemical assays of androgen binding in whole
preoptic area and/or hypothalamus dissections have
not revealed sex diVerences.29,48 However, measuring
AR binding in more discrete nuclei within the pre-
optic area and hypothalamus has demonstrated sex
diVerences.47 In particular, the caudal part of the
mPOA showed sex diVerences, with males having
more testosterone target neurons that project to the
midbrain than females.36 This might not be proof for
sex diVerences in ARs, since testosterone can be
aromatized to estradiol within the CNS. Therefore, a
labeled cell following an injection of radioactively
labeled testosterone may represent estrogen binding
to ERs. Sex diVerences in AR levels have been found
during the first 10 days of life, especially in the
amygdala.38 In this latter study, however, males and
females were left gonadally intact, which makes it
very likely that the sex diVerences in AR levels reflect
sex diVerences in endogenous testosterone or di-
hydrotestosterone levels. Presumably, there are no
large sex diVerences in the distributions and densities
of AR-containing cells, although small, subtle
quantitative diVerences in certain regions of the male
and female rat brain cannot be ruled out. It seems
unlikely that possible sex diVerences in AR levels
are caused by the actions of estrogen during early
development, since neonatally ATD-treated males
showed similar distributions and densities of AR-IR
as control males. However, no female controls were
used in the present study, so it is not known whether
or not any sex diVerences in AR levels would have
been found using the assay conditions of the present
study. Therefore, we cannot determine from the
present data whether or not sexual diVerentiation of
forebrain ARs occurs and, if it happens, whether it
takes place pre- or neonatally under the influence of
androgens or estrogens.9,10,43,45,51,53 Future studies
should address these questions.
Interestingly, a dense cluster of AR-IR was found
in the SDN-POA (see Fig. 2), as was reported earlier
for AR mRNA by Simerly et al.50 This was not seen
with ER-IR. In the adult rat, the volume of the
SDN-POA is determined by the perinatal action of
androgens.21,22,23,30,32 Jacobson et al.31 have found
that gonadectomized and adrenalectomized male
rats showed a higher percentage of radioactively
labeled cells in the SDN-POA following exposure to
[3H]testosterone than gonadectomized and adrenal-
ectomized females.31 This sex diVerence might be due
to a diVerence in AR levels in the mPOA.29 In the
present study, no eVect of neonatal ATD treatment
was found on the number of ARs in the SDN-POA
or on the SDN-POA occupied by ARs. We expect
that the volume of the SDN-POA of neonatally
ATD-treated males is smaller than that of control
males, since perinatal ATD treatment to male rats
reduced SDN-POA volume in adulthood.30 Presum-
ably, the absence of changes in the number of ARs in
the SDN-POA or in the SDN-POA occupied by ARs
suggests that there are either no changes in the size of
the SDN-POA or that AR immunostaining in the
SDN-POA has increased with ATD treatment to
compensate for the smaller size. We are currently
studying the SDN-POA volume in neonatally
ATD-treated male rats.
It has been suggested that the binding of the PG-21
antiserum to androgen receptors requires occupation
of the receptor. Zhou et al.58 reported that testoster-
one withdrawal by castration eliminated all nuclear
staining, whereas dihydrotestosterone or testosterone
treatment 15 min before perfusion restored nuclear
staining. In the present study, the ATD and control
males were left gonadally intact for the AR immuno-
cytochemistry. We do not believe that the number of
occupied ARs diVers between neonatally ATD-
treated males and control males, since neonatally
ATD-treated males and control males have similar
levels of endogenous testosterone.6
CONCLUSIONS
The available evidence points to sex diVerences in
ER levels in the PVP, mPOA, Arc and VMH. The
development of these sex diVerences in forebrain ER
levels seems to be partly dependent on the neonatal
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action of estrogens, derived from the neural aroma-
tization of testosterone. To date, it is not clear
whether or not sexual diVerentiation of forebrain
ARs occurs and, if so, whether there is any contri-
bution of neonatal estrogens to the development of
the AR system.
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